The need to better understand Treg plasticity and function in the context of autoimmunity
S. Alice Long and Jane H. Buckner “CD4+ FOXP3+ T Regulatory cells in Human Autoimmunity: More than a Numbers Game” J Immunol (2011) 187:2061-2066
S. Alice Long and Jane H. Buckner “CD4+ FOXP3+ T Regulatory cells in Human Autoimmunity: More than a Numbers Game” J Immunol (2011) 187:2061-2066
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice. Gaspal F.M., P.J.L Lane, et al. (2011) JEM 208(8): 1579-1584. Ancell Products anti-human CD30 antibody products anti-human CD134(OX40) antibody products anti-human CD252(OX40L) antibody products Recombinant human CD134(OX40) Recombinant human CD252(OX40L)
CD30 and CD134 receptors are necessary for CD4 dependent autoimmune tissue damage Read More »
New anti-Mouse CD4 PE-Cy7 conjugate available now! Watch for more PE-Cy7 conjugates available soon.
New anti-Mouse CD4 PE-Cy7 conjugate Read More »
Ancell announces partnership with HelioCyte to provide cutting edge Flow Cytometry products! Watch for new products designed to simplify and improve your Flow research! Twitter account: Heliocyte
Ancell announces partnership with HelioCyte! Read More »
Improved multi-color staining of Mouse tissues Anti-Mouse CD4 (clone GK1.5)/DyLight350* conjugate now available! Catalog #704-350 DyLight350* is excitable by Near-UV laser Amax 353, and emits in the blue range, Emax 432nm. Look for more DyLight350 conjugates available soon!
anti-Mouse CD4/DyLight350 conjugate Read More »
Engagement of CD134(OX40) by its Ligand (CD252) induces an intracellular signaling complex which includes PKB, and PI3K, and requires TRAF2. Takanori S, H Choi, M Croft. (2011) J Immunol 186(6):3547-3555. Ancell Products: Recombinant human CD134-muIg Fusion protein Recombinant human CD252(OX40)-muCD8 Monoclonal anti-human CD134(OX40) Monoclonal anti-human CD252(OX40L)
CD134(OX40) Signaling Mechanism Elucidated Read More »
In mice, use of CD28 superagonist has been shown to increase the % of Treg cells, and protect from Rheumatoid Arthritis mediated bone destruction.Marlo M Zaiss, Jean-Pierre David, et al. (2010) J Immunol 184: 7238-7246. Ancell anti-CD28 antibody clone ANC28.1/5D10 has been characterized as a superagonist. This mAb has been found to be capable of stimulating
CD28 Superagonist protects against Rheumatoid Arthritis mediated bone destruction Read More »